Skip to main content
NCBI home page
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1998 Mar-Apr;71(2):125–133.

Eradication of Helicobacter pylori infection in the management of patients with dyspepsia and non-ulcer dyspepsia.

J Q Huang 1, R H Hunt 1
PMCID: PMC2578897  PMID: 10378358

Abstract

Although H. pylori infection has been recognized as a major etiological agent for the development of chronic active gastritis, duodenal ulcer and benign non-NSAID related gastric ulcer, its role in the development of symptoms in patients with dyspepsia remains uncertain. Results from population-based epidemiological studies have been conflicting regarding a causal link between H. pylori infection and dyspepsia. Abnormalities in gastric acid secretion may exist in some dyspeptic patients. Whether disordered gastric motility seen in dyspeptic patients is related to the infection is not clear based on the results in the literature. Numerous clinical trials have been undertaken to eradicate H. pylori infection and improve the symptoms in dyspeptic patients; however, the results have been discrepant between studies. Many published studies suffer from methodological problems that have made interpretation difficult. Large, well-conducted, randomized, placebo-controlled, clinical trials with long-term follow-up are needed to justify the beneficial effect of H. pylori eradication treatment in dyspeptic patients seen in some small studies. H. pylori eradication therapy is cost-effective in H. pylori-infected dyspeptic patients although this benefit may take a long time to accrue, especially in younger patients.

Full text

PDF
125

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bernersen B., Johnsen R., Bostad L., Straume B., Sommer A. I., Burhol P. G. Is Helicobacter pylori the cause of dyspepsia? BMJ. 1992 May 16;304(6837):1276–1279. doi: 10.1136/bmj.304.6837.1276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Blecker U., Lanciers S., Hauser B., Vandenplas Y. The prevalence of Helicobacter pylori positivity in a symptom-free population, aged 1 to 40 years. J Clin Epidemiol. 1994 Oct;47(10):1095–1098. doi: 10.1016/0895-4356(94)90095-7. [DOI] [PubMed] [Google Scholar]
  3. Briggs A. H., Sculpher M. J., Logan R. P., Aldous J., Ramsay M. E., Baron J. H. Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age. BMJ. 1996 May 25;312(7042):1321–1325. doi: 10.1136/bmj.312.7042.1321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bytzer P. Diagnosing dyspepsia: any controversies left? Gastroenterology. 1996 Jan;110(1):302–306. doi: 10.1053/gast.1996.v110.agast960302. [DOI] [PubMed] [Google Scholar]
  5. Chang C. S., Chen G. H., Kao C. H., Wang S. J., Peng S. N., Huang C. K. The effect of Helicobacter pylori infection on gastric emptying of digestible and indigestible solids in patients with nonulcer dyspepsia. Am J Gastroenterol. 1996 Mar;91(3):474–479. [PubMed] [Google Scholar]
  6. Chiba N., Rao B. V., Rademaker J. W., Hunt R. H. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol. 1992 Dec;87(12):1716–1727. [PubMed] [Google Scholar]
  7. Collins J. S., Hamilton P. W., Watt P. C., Sloan J. M., Love A. H. Superficial gastritis and Campylobacter pylori in dyspeptic patients--a quantitative study using computer-linked image analysis. J Pathol. 1989 Aug;158(4):303–310. doi: 10.1002/path.1711580407. [DOI] [PubMed] [Google Scholar]
  8. Elta G. H., Scheiman J. M., Barnett J. L., Nostrant T. T., Behler E. M., Crause I., Appelman H. D. Long-term follow-up of Helicobacter pylori treatment in non-ulcer dyspepsia patients. Am J Gastroenterol. 1995 Jul;90(7):1089–1093. [PubMed] [Google Scholar]
  9. Gilja O. H., Hausken T., Wilhelmsen I., Berstad A. Impaired accommodation of proximal stomach to a meal in functional dyspepsia. Dig Dis Sci. 1996 Apr;41(4):689–696. doi: 10.1007/BF02213124. [DOI] [PubMed] [Google Scholar]
  10. Greenberg R. E., Bank S. The prevalence of Helicobacter pylori in nonulcer dyspepsia. Importance of stratification according to age. Arch Intern Med. 1990 Oct;150(10):2053–2055. [PubMed] [Google Scholar]
  11. Harris A. W., Gummett P. A., Misiewicz J. J., Baron J. H. Eradication of Helicobacter pylori in patients with duodenal ulcer lowers basal and peak acid outputs to gastrin releasing peptide and pentagastrin. Gut. 1996 May;38(5):663–667. doi: 10.1136/gut.38.5.663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Holcombe C., Umar H., Lucas S. B., Kaluba J. Low incidence of clinically significant gastroduodenal pathology despite a high incidence of Helicobacter pylori infection. Trans R Soc Trop Med Hyg. 1994 Sep-Oct;88(5):569–571. doi: 10.1016/0035-9203(94)90166-x. [DOI] [PubMed] [Google Scholar]
  13. Holtmann G., Talley N. J., Goebell H. Association between H. pylori, duodenal mechanosensory thresholds, and small intestinal motility in chronic unexplained dyspepsia. Dig Dis Sci. 1996 Jul;41(7):1285–1291. doi: 10.1007/BF02088548. [DOI] [PubMed] [Google Scholar]
  14. Hovelius B., Andersson S. I., Hagander B., Mölstad S., Reimers P., Sperlich E., Wadström T. Dyspepsia in general practice: history and symptoms in relation to Helicobacter pylori serum antibodies. Scand J Gastroenterol. 1994 Jun;29(6):506–510. doi: 10.3109/00365529409092463. [DOI] [PubMed] [Google Scholar]
  15. Kang J. Y., Fock K. M., Ng H. S., Ho K. T., Chee A. Working party report of the Gastroenterological Society of Singapore. Part II--Helicobacter pylori and non-ulcer dyspepsia in Singapore. Singapore Med J. 1996 Aug;37(4):428–429. [PubMed] [Google Scholar]
  16. Kang J. Y., Tay H. H., Wee A., Guan R., Math M. V., Yap I. Effect of colloidal bismuth subcitrate on symptoms and gastric histology in non-ulcer dyspepsia. A double blind placebo controlled study. Gut. 1990 Apr;31(4):476–480. doi: 10.1136/gut.31.4.476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Karttunen T., Niemelä S., Lehtola J. Helicobacter pylori in dyspeptic patients: quantitative association with severity of gastritis, intragastric pH, and serum gastrin concentration. Scand J Gastroenterol Suppl. 1991;186:124–134. doi: 10.3109/00365529109103999. [DOI] [PubMed] [Google Scholar]
  18. Laheij R. J., Jansen J. B., van de Lisdonk E. H., Severens J. L., Verbeek A. L. Review article: symptom improvement through eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. Aliment Pharmacol Ther. 1996 Dec;10(6):843–850. doi: 10.1046/j.1365-2036.1996.86258000.x. [DOI] [PubMed] [Google Scholar]
  19. Lambert J. R., Dunn K., Borromeo M., Korman M. G., Hansky J. Campylobacter pylori--a role in non-ulcer dyspepsia? Scand J Gastroenterol Suppl. 1989;160:7–13. doi: 10.3109/00365528909091728. [DOI] [PubMed] [Google Scholar]
  20. Lazzaroni M., Bargiggia S., Sangaletti O., Maconi G., Boldorini M., Bianchi Porro G. Eradication of Helicobacter pylori and long-term outcome of functional dyspepsia. A clinical endoscopic study. Dig Dis Sci. 1996 Aug;41(8):1589–1594. doi: 10.1007/BF02087905. [DOI] [PubMed] [Google Scholar]
  21. Management of dyspepsia: report of a working party. Lancet. 1988 Mar 12;1(8585):576–579. [PubMed] [Google Scholar]
  22. Marshall B. J., Valenzuela J. E., McCallum R. W., Dooley C. P., Guerrant R. L., Cohen H., Frierson H. F., Jr, Field L. G., Jerdack G. R., Mitra S. Bismuth subsalicylate suppression of Helicobacter pylori in nonulcer dyspepsia: a double-blind placebo-controlled trial. Dig Dis Sci. 1993 Sep;38(9):1674–1680. doi: 10.1007/BF01303177. [DOI] [PubMed] [Google Scholar]
  23. Marzio L., Falcucci M., Ciccaglione A. F., Malatesta M. G., Lapenna D., Ballone E., Antonelli C., Grossi L. Relationship between gastric and gallbladder emptying and refilling in normal subjects and patients with H. pylori-positive and -negative idiopathic dyspepsia and correlation with symptoms. Dig Dis Sci. 1996 Jan;41(1):26–31. doi: 10.1007/BF02208580. [DOI] [PubMed] [Google Scholar]
  24. McCarthy C., Patchett S., Collins R. M., Beattie S., Keane C., O'Morain C. Long-term prospective study of Helicobacter pylori in nonulcer dyspepsia. Dig Dis Sci. 1995 Jan;40(1):114–119. doi: 10.1007/BF02063953. [DOI] [PubMed] [Google Scholar]
  25. Mearin F., Cucala M., Azpiroz F., Malagelada J. R. The origin of symptoms on the brain-gut axis in functional dyspepsia. Gastroenterology. 1991 Oct;101(4):999–1006. doi: 10.1016/0016-5085(91)90726-2. [DOI] [PubMed] [Google Scholar]
  26. Mearin F., de Ribot X., Balboa A., Salas A., Varas M. J., Cucala M., Bartolomé R., Armengol J. R., Malagelada J. R. Does Helicobacter pylori infection increase gastric sensitivity in functional dyspepsia? Gut. 1995 Jul;37(1):47–51. doi: 10.1136/gut.37.1.47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Minocha A., Mokshagundam S., Gallo S. H., Rahal P. S. Alterations in upper gastrointestinal motility in Helicobacter pylori-positive nonulcer dyspepsia. Am J Gastroenterol. 1994 Oct;89(10):1797–1800. [PubMed] [Google Scholar]
  28. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA. 1994 Jul 6;272(1):65–69. [PubMed] [Google Scholar]
  29. Noach L. A., Bosma N. B., Jansen J., Hoek F. J., van Deventer S. J., Tytgat G. N. Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol. 1994 May;29(5):425–429. doi: 10.3109/00365529409096833. [DOI] [PubMed] [Google Scholar]
  30. Ofman J. J., Etchason J., Fullerton S., Kahn K. L., Soll A. H. Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: clinical and economic consequences. Ann Intern Med. 1997 Feb 15;126(4):280–291. doi: 10.7326/0003-4819-126-4-199702150-00004. [DOI] [PubMed] [Google Scholar]
  31. Parente F., Maconi G., Sangaletti O., Minguzzi M., Vago L., Rossi E., Bianchi Porro G. Prevalence of Helicobacter pylori infection and related gastroduodenal lesions in spouses of Helicobacter pylori positive patients with duodenal ulcer. Gut. 1996 Nov;39(5):629–633. doi: 10.1136/gut.39.5.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Parsonnet J., Blaser M. J., Perez-Perez G. I., Hargrett-Bean N., Tauxe R. V. Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology. 1992 Jan;102(1):41–46. doi: 10.1016/0016-5085(92)91782-y. [DOI] [PubMed] [Google Scholar]
  33. Pounder R. E., Ng D. The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther. 1995;9 (Suppl 2):33–39. [PubMed] [Google Scholar]
  34. Rauws E. A., Langenberg W., Houthoff H. J., Zanen H. C., Tytgat G. N. Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology. 1988 Jan;94(1):33–40. [PubMed] [Google Scholar]
  35. Rokkas T., Pursey C., Uzoechina E., Dorrington L., Simmons N. A., Filipe M. I., Sladen G. E. Campylobacter pylori and non-ulcer dyspepsia. Am J Gastroenterol. 1987 Nov;82(11):1149–1152. [PubMed] [Google Scholar]
  36. Schweizer A., Feige U., Fontana A., Müller K., Dinarello C. A. Interleukin-1 enhances pain reflexes. Mediation through increased prostaglandin E2 levels. Agents Actions. 1988 Dec;25(3-4):246–251. doi: 10.1007/BF01965025. [DOI] [PubMed] [Google Scholar]
  37. Schütze K., Hentschel E., Hirschl A. M. Clarithromycin or amoxycillin plus high-dose ranitidine in the treatment of Helicobacter pylori-positive functional dyspepsia. Eur J Gastroenterol Hepatol. 1996 Jan;8(1):41–46. doi: 10.1097/00042737-199601000-00008. [DOI] [PubMed] [Google Scholar]
  38. Sheu B. S., Lin C. Y., Lin X. Z., Shiesh S. C., Yang H. B., Chen C. Y. Long-term outcome of triple therapy in Helicobacter pylori-related nonulcer dyspepsia: a prospective controlled assessment. Am J Gastroenterol. 1996 Mar;91(3):441–447. [PubMed] [Google Scholar]
  39. Silverstein M. D., Petterson T., Talley N. J. Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis. Gastroenterology. 1996 Jan;110(1):72–83. doi: 10.1053/gast.1996.v110.pm8536890. [DOI] [PubMed] [Google Scholar]
  40. Sonnenberg A. Cost-benefit analysis of testing for Helicobacter pylori in dyspeptic subjects. Am J Gastroenterol. 1996 Sep;91(9):1773–1777. [PubMed] [Google Scholar]
  41. Strauss R. M., Wang T. C., Kelsey P. B., Compton C. C., Ferraro M. J., Perez-Perez G., Parsonnet J., Blaser M. J. Association of Helicobacter pylori infection with dyspeptic symptoms in patients undergoing gastroduodenoscopy. Am J Med. 1990 Oct;89(4):464–469. doi: 10.1016/0002-9343(90)90377-p. [DOI] [PubMed] [Google Scholar]
  42. Talley N. J. A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia. Gastroenterology. 1994 May;106(5):1174–1183. doi: 10.1016/0016-5085(94)90007-8. [DOI] [PubMed] [Google Scholar]
  43. Talley N. J. Modern management of dyspepsia. Aust Fam Physician. 1996 Jan;25(1):47–52. [PubMed] [Google Scholar]
  44. Talley N. J., Phillips S. F. Non-ulcer dyspepsia: potential causes and pathophysiology. Ann Intern Med. 1988 Jun;108(6):865–879. doi: 10.7326/0003-4819-108-6-865. [DOI] [PubMed] [Google Scholar]
  45. Talley N. J., Zinsmeister A. R., Schleck C. D., Melton L. J., 3rd Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology. 1992 Apr;102(4 Pt 1):1259–1268. [PubMed] [Google Scholar]
  46. Trespi E., Broglia F., Villani L., Luinetti O., Fiocca R., Solcia E. Distinct profiles of gastritis in dyspepsia subgroups. Their different clinical responses to gastritis healing after Helicobacter pylori eradication. Scand J Gastroenterol. 1994 Oct;29(10):884–888. doi: 10.3109/00365529409094858. [DOI] [PubMed] [Google Scholar]
  47. Veldhuyzen van Zanten S. J. The role of Helicobacter pylori infection in non-ulcer dyspepsia. Aliment Pharmacol Ther. 1997 Apr;11 (Suppl 1):63–69. doi: 10.1046/j.1365-2036.11.s1.15.x. [DOI] [PubMed] [Google Scholar]
  48. Verdú E. F., Fraser R., Tiberio D., Herranz M., Sipponen P., Blum A. L., Michetti P. Prevalence of Helicobacter pylori infection and chronic dyspeptic symptoms among immigrants from developing countries and people born in industrialized countries. Digestion. 1996;57(3):180–185. doi: 10.1159/000201334. [DOI] [PubMed] [Google Scholar]
  49. Wegener M., Börsch G., Schaffstein J., Schulz-Flake C., Mai U., Leverkus F. Are dyspeptic symptoms in patients with Campylobacter pylori-associated type B gastritis linked to delayed gastric emptying? Am J Gastroenterol. 1988 Jul;83(7):737–740. [PubMed] [Google Scholar]
  50. Wilhelmsen I., Tangen Haug T., Sipponen P., Berstad A. Helicobacter pylori in functional dyspepsia and normal controls. Scand J Gastroenterol. 1994 Jun;29(6):522–527. doi: 10.3109/00365529409092466. [DOI] [PubMed] [Google Scholar]
  51. Witteman E. M., Mravunac M., Becx M. J., Hopman W. P., Verschoor J. S., Tytgat G. N., de Koning R. W. Improvement of gastric inflammation and resolution of epithelial damage one year after eradication of Helicobacter pylori. J Clin Pathol. 1995 Mar;48(3):250–256. doi: 10.1136/jcp.48.3.250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. el-Omar E., Penman I., Ardill J. E., McColl K. E. A substantial proportion of non-ulcer dyspepsia patients have the same abnormality of acid secretion as duodenal ulcer patients. Gut. 1995 Apr;36(4):534–538. doi: 10.1136/gut.36.4.534. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES